Events

30.08.2014 - 04.09.2014

FEBS-EMBO 2014 Conference

Paris (F)

The FEBS–EMBO 2014 Conference will be a unique international event that brings together many leading researchers to discuss the latest scientific findings in the life sciences. Scientists from across the world will be able to attend a jointly organized conference that offers unparalleled scope for the entire range of the molecular life sciences. The conference will also celebrate the 50th anniversaries of FEBS and EMBO and the 100th anniversary of the French Society for Biochemistry and Molecular Biology.
Contact:
communications@embo.org

03.09.2014 - 04.09.2014

XXVI. Genetic Days 2014

Prague (CZ)

The conference has a long tradition (50-year history) and is organized regularly every two years in different places, Czech Republic, Poland and Slovak Republic. Conference will be focused on: Animal molecular genetics; Animal breeding and genetics; Plant molecular genetics and breeding; Genetics of microorganisms. Courses for young researchers in the fields of molecular and quantitative genetics and genetic evaluation of animals will be organized before the conference.
Contact: Czech University of Life Sciences

10.09.2014 - 11.09.2014

Biomarker Utilisation & Commercialisation

London (UK)

The conference will explore the value of biomarkers from both a clinical and commercial perspective. The aim is to help end-users to develop a comprehensive strategy for biomarker discovery, development, application and analysis in clinical trials.
Contact: ACI – Active Communications International

15.09.2014 - 19.09.2014

14th International Conference on Plasma Surface Engineering

Garmisch-Partenkirchen (GER)

The biennial PSE conference series is organized by the European Joint Committee on Plasma and Ion Surface Engineering. PSE provides an opportunity to present recent progress in research and development and industrial applications. Its topics span a wide range from fundamentals such as e.g. process modelling and simulation of plasmas or thin film physics, through empirical studies which e.g. establish the relationships between process parameters and the structural and functional properties of modified surfaces and/or thin films, towards the application in industrial production.
Contact: EFDS e.V.
pse2014@efds.org

Translating the New Clinical Trials Regulation into Practice/Translating the New Transparency Requirements into Practice

Media-Partner

23.09.2014 - 25.09.2014

Translating the New Clinical Trials Regulation into Practice/Translating the New Transparency Requirements into Practice

London (UK)

Clinical Trials Workshop I and II – Combining Pricing
Workshop I will provide a forum for information exchange and discussion on conceptual and practical questions through lectures, panel discussions, and interactive break-out sessions. Day 1 will focus on the new provisions for submission, assessment and decision-making of clinical trial applications, and the management and monitoring of trials. Day 2 will focus on the new transparency provisions for clinical trials.
Workshop II on clinical data transparency will focus on practical considerations for the disclosure of clinical trials data. Attendees can participate in either one workshop or in the entire 3-day program. The two workshops will overlap with a day addressing the Transparency aspects of the Clinical Trials Regulation.
Contact: DIA Europe
Phone: +41 61 225 51 51, Fax: +41 61 225 51 52
diaeurope@diaeurope.org

23.09.2014 - 24.09.2014

7th EPLS-Meeting

Prague (CZ)

The programme will include presentations from those within the industry together with the introduction of interactive sessions such as ‘talking tables’ and a panel discussion on Tuesday afternoon. There will be the traditional extended breaks to allow for informal networking throughout the event alongside the more formal one-to-one meeting area.
Contact: Pharmaceutical Licensing Group Ltd.

Joint DIA/FIP Workshop Biorelevant Performance Testing of Orally Administered Dosage Forms

Media-Partner

24.09.2014 - 25.09.2014

Joint DIA/FIP Workshop Biorelevant Performance Testing of Orally Administered Dosage Forms

Amsterdam (NL)

This workshop will discuss data on the lumenal environment, its simulation, biorelevant in vitro performance testing methodologies that can be applied during product development, as well as relevant in silico modelling methodologies. Case studies from industry will describe the application of biorelevant testing methodologies for formulation design, selection and development vs. currently applied procedures in quality control testing. In addition, presentations from the FDA and National Competent Authorities will cover the use of biorelevant testing in the evaluation of a drug’s performance. - See more at: www.diahome.org/en-GB/Meetings-and-Training/Find-Meetings-and-Training/Meeting-Details.aspx
Contact: DIA Europe
Phone: +41 61 225 51 51, Fax: +41 61 225 51 52
diaeurope@diaeurope.org

BioSpain 2014

Media-Partner

24.09.2014 - 26.09.2014

BioSpain 2014

Santiago de Compostela (ES)

International Meeting on Biotechnology – trade exhibition, partnering event, investment forum, scientific congress, top level seminars & conferences and a career fair with a well balanced mixture of local and international private companies, universities, overseas clusters, research institutes and governmental bodies.
Contact: David Fernandez, asebio
dfernandez@biospain2014.org

30.09.2014 - 01.10.2014

14th Annual Biotech in Europe Forum

Basel (CH)

The forum is the stage for those interested in investing and partnering in the biotech and life science industry and is highly transactional. It draws together an cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives.
Contact: Mina Orda, Sachs Associates
mina@sachsforum.com

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/service/events.html?cHash=69150c326ccb19e0a7fbfef47fc9f0c1&events%255Buid%255D=4485&events%255Bmonth%255D=1351724400

Events

All Events

Stock list

All quotes

TOP

  • BIOINVENT INTERNATIONAL AB (S)3.10 SEK9.15%
  • Allergy Therapeutics (UK)19.12 GBP6.94%
  • PHARMING (NL)0.48 EUR6.67%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • CHRONTECH PHARMA (S)0.07 SEK-12.50%

TOP

  • WILEX (D)3.15 EUR331.5%
  • SANTHERA (CH)68.55 CHF99.3%
  • ADDEX (CH)4.08 CHF85.5%

FLOP

  • MERCK KGAA (D)65.43 EUR-48.6%
  • HYBRIGENICS (F)1.83 EUR-29.1%
  • PROSENSA (NL)9.48 USD-26.2%

TOP

  • SANTHERA (CH)68.55 CHF3489.0%
  • GW PHARMACEUTICALS (UK)427.00 GBP780.4%
  • PAION (D)2.79 EUR304.3%

FLOP

  • CYTOS (CH)0.26 CHF-92.4%
  • EVOCUTIS (UK)0.21 GBP-92.0%
  • PROSENSA (NL)9.48 USD-68.2%

No liability assumed, Date: 24.07.2014

Job Advert

Executive Director of the IMI Joint Undertaking

The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries Associations (EFPIA).
The Executive Director will lead and manage the Joint Undertaking and take overall responsibility for its operations ensuring the achievement of the Joint Undertaking's objectives. more...


Current issue

All issues

Product of the week

Products